LDR’s IPO Bid, FDA Approvals Give Spine Much Needed Adjustment
This article was originally published in The Gray Sheet
Executive Summary
The spine device firm LDR filed to raise up to $69 million in an initial public offering just as it gained FDA approval for its Mobi-C cervical disc for one- and two-level indications. Device investors will keep a close watch on the IPO, which has not been staged by a venture-backed spine startup since 2007.
You may also be interested in...
Cervical Disc Replacement Data Looks Good, But More Needed
Long-term positive outcomes for artificial cervical discs were reported, but the market remains muted by insurance restrictions, and even more data may be needed for a breakthrough.
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.